Welcure Drugs Statements
52
Data from Welcure Drugs`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
INR - Indian rupee
Last reporting period:
30 Sep, 2023
Next reporting period:
28 Mar, 2024
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Welcure Drugs Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
100
—
0
—
—
0
—
0
0.27
0
1.236
72.1 %
0
-1.236
-72.1 %
0
—
0
0.024
0
-1.282
-104.1 %
0
—
0
-1.282
-104.1 %
0
-0.072
89.756
—
-100 %
100
—
0
—
—
0
—
0
0.072
0
0.718
232.1 %
0
-0.718
-217.9 %
0
—
0
0.09
0
-0.628
-202.8 %
0
—
0
-0.628
-202.8 %
0
-0.046
13.476
0.825
266.7 %
100
—
0
—
—
0
—
0
0.074
4.4
0.216
-64 %
18.9
0.609
262.3 %
81.1
—
0
0.002
0
0.611
262.9 %
81.1
—
0
0.611
262.9 %
81.1
0.036
13.412
0.225
-56.7 %
100
—
0
—
—
0
—
0
0.057
0
0.6
282.2 %
0
-0.375
-203.3 %
0
—
0
—
0
-0.375
-204.5 %
0
—
0
-0.375
-204.5 %
0
-0.03
12.75
0.52
-36 %
100
—
0
—
—
0
—
0
0.042
4
0.157
-75 %
22.7
0.363
95.2 %
77.3
—
0
-0.004
-0.8
0.359
87 %
76.5
—
0
0.359
87 %
76.5
0.03
12.119
0.813
713 %
100
—
0
0.813
—
100
—
0
0.042
6.9
0.627
126.5 %
57.4
0.186
205.2 %
42.6
—
0
0.006
2
0.192
210.8 %
44.6
—
0
0.192
210.8 %
44.6
0.016
12.119
0.1
-86.2 %
100
—
0
—
—
0
—
0
0.042
21
0.277
-57.2 %
168.8
-0.177
-323.8 %
-68.8
—
0
0.004
3.5
-0.173
-319.4 %
-65.3
—
0
-0.173
-319.4 %
-65.3
-0.014
12.119
0.725
—
100
—
0
0.725
—
100
—
0
0.042
7
0.646
—
62
0.079
—
38
—
0
—
0
0.079
—
38
—
0
0.079
—
38
0.007
12.119